Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

APPLIED DNA SCIENCES INC Director's Dealing 2026

Feb 13, 2026

35347_dirs_2026-02-13_5bdf963f-d036-4e24-8803-ec45f20da36a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BNB PLUS CORP. (BNBX)
CIK: 0000744452
Period of Report: 2026-02-02

Reporting Person: Haft James (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-02 Incentive Stock Option (right to buy) $1.31 A 80730 Acquired 2036-02-02 Common Stock (80730) Direct
2026-02-02 Non-Qualified Stock Option (right to buy) $1.31 A 12270 Acquired 2036-02-02 Common Stock (12270) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 22590 Direct

Footnotes

F1: The options vest in four equal installments on May 2, 2026, August 2, 2026, November 2, 2026 and February 2, 2027.